Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phosphate & Kidney Stones
Sponsor: University of Chicago
Summary
Kidney stones are common and often come back. One reason may be that some people with calcium stones have low phosphate levels in the blood and lose too much phosphate through the kidneys. They may also have high calcium in the urine, which raises the chance of forming stones. In older studies, high doses of phosphate supplements lowered urine calcium and appeared to reduce stone formation, but they sometimes caused stomach and bowel side effects, and phosphate is no longer used for stone prevention. This small pilot study will test a much lower dose of neutral phosphate (250 mg twice daily) for 2 weeks in adults with recurrent calcium oxalate kidney stones, high urine calcium, and low blood phosphate. Participants will collect a 24-hour urine sample and have blood drawn before and after the 2-week period. The study will look at whether the low dose reduces urine calcium and the risk of stone formation in urine. The results will help decide whether a larger study is warranted.
Official title: Pilot Study of Low-Dose Neutral Phosphate Supplementation for Reducing Urine Calcium and Supersaturation in Patients With Recurrent Calcium Oxalate Kidney Stones and Hypophosphatemia
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
5
Start Date
2026-10-31
Completion Date
2028-01-31
Last Updated
2026-10-29
Healthy Volunteers
No
Interventions
Neutral Phosphate
250 mg of oral neutral phosphate taken twice daily for 2 weeks (500 mg total per day). The study drug is dispensed by the University of Chicago Investigational Drug Service. Participants take it at home and are assessed for side effects and adherence by a 1-week phone call and again at the 2-week study visit.
Locations (1)
University of Chicago
Chicago, Illinois, United States